Table 1.
Patient Characteristics
| n | % | |
|---|---|---|
| No. of Patients | 129,040 | 100% |
| Age | ||
| 65–69 | 38,298 | 29.7% |
| 70–74 | 32,823 | 25.4% |
| 75–79 | 26,475 | 20.5% |
| 80–84 | 18,442 | 14.3% |
| 85+ | 13,002 | 10.1% |
| Female | 63,689 | 49.4% |
| Race/Ethnicity | ||
| American Indian/Alaska Native | 444 | 0.3% |
| Asian | 13,306 | 10.3% |
| Black | 10,063 | 7.8% |
| Hispanic | 16,492 | 12.8% |
| Native Hawaiian/Pacific Islander | 633 | 0.5% |
| White | 75,880 | 58.8% |
| Race Missing/Unknown | 12,222 | 9.5% |
| Enrolled for 12 months | 119,777 | 92.8% |
| Anxiety | 6,295 | 4.9% |
| Arthritis | 31,650 | 24.5% |
| Atrial Fibrillation | 13,114 | 10.2% |
| COPD | 11,879 | 9.2% |
| Depression | 16,655 | 12.9% |
| Heart Failure | 15,309 | 11.9% |
| Poorly Controlled Hyperlipidemia (LDL≥100) | 23,104 | 17.9% |
| Poorly Controlled Hypertension (SBP≥130) | 47,611 | 36.9% |
| Poorly Controlled Hyperglycemia (A1c≥8%) | 14,539 | 11.3% |
| Insulin Use | 27,945 | 21.7% |
| Fills or Orders in 2010 for ACEI/ARB | 95,395 | 73.9% |
| Fills or Orders in 2010 for Statin | 103,808 | 80.4% |
| Fills or Orders in 2010 for Oral Diabetes Drug | 78,743 | 61.0% |
| Mean Number of Medications at Study Start (Std Dev) | 5.32 (3.49) | |
| Mean Days Supply of ACEI/ARB (Std Dev) | 91.28 (17.91) | |
| Mean Days Supply of Statins (Std Dev) | 89.15 (17.22) | |
| Mean Days Supply of Oral DM Drugs (Std Dev) | 89.83 (18.82) |
| Table 1b. Patient Characteristics by Whether Included in Medicare STAR Medication Adherence Metric | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Patients with ACEI/ARB Fills or Orders in 2010 (n=95,395) |
Patients with Oral Diabetes Drug Fills or Orders in 2010 (n=78,743) |
Patients with Statin Fills or Orders in 2010 (n=103,808) |
|||||||
| Adherent: PDC≥80% |
Non- adherent: PDC<80% |
Excluded | Adherent: PDC≥80% |
Non- adherent: PDC<80% |
Excluded | Adherent: PDC≥80% |
Non- adherent: PDC<80% |
Excluded | |
| n (%) | 69,402 (73%) | 16,718 (17%) | 9,275 (10%) | 46,406 (59%) | 10,223 (13%) | 22,114 (28%) | 73,582 (71%) | 19,694 (19%) | 10,532 (10%) |
| Age | |||||||||
| 65–69 | 32% | 30%*** | 30%*** | 33% | 31%* | 35%*** | 30% | 32%*** | 31% |
| 70–74 | 27% | 26%** | 24%*** | 27% | 25%*** | 27% | 27% | 26% | 25%*** |
| 75–79 | 21% | 20% | 20% | 20% | 20% | 19%** | 21% | 20%*** | 19%*** |
| 80–84 | 13% | 14%*** | 14%*** | 13% | 14%*** | 12%*** | 14% | 14% | 14% |
| 85+ | 7% | 10%*** | 12%*** | 7% | 10%*** | 7%* | 8% | 9%** | 11%*** |
| Race/Ethnicity | |||||||||
| White | 60% | 56%*** | 55%*** | 56% | 52%*** | 59%*** | 61% | 54%*** | 52%*** |
| Hispanic | 12% | 15%*** | 14%*** | 13% | 15%*** | 15%*** | 12% | 15%*** | 15%*** |
| Asian | 11% | 11% | 12%* | 13% | 11%*** | 10%*** | 11% | 11% | 12% |
| Race Missing/Unknown | 10% | 9%** | 10% | 11% | 11% | 8%*** | 9% | 10% | 11%*** |
| Black | 7% | 9%*** | 9%*** | 7% | 10%*** | 8%*** | 7% | 10%*** | 10%*** |
| American Indian/Alaska Native | <1% | <1% | <1% | <1% | <1% | <1% | <1% | <1%* | <1%* |
| Female | 49% | 51%** | 48%** | 48% | 51%*** | 48% | 48% | 52%*** | 51%*** |
| Anxiety | 4% | 5%*** | 5%** | 4% | 5%*** | 4%** | 4% | 6%*** | 5%*** |
| Arthritis | 24% | 25% | 23%*** | 23% | 24%* | 23% | 25% | 25% | 23%*** |
| Atrial Fibrillation | 9% | 10%** | 11%*** | 8% | 8% | 10%*** | 10% | 9%** | 9%** |
| COPD | 8% | 10%*** | 11%*** | 7% | 9%*** | 10%*** | 9% | 10%*** | 9% |
| Depression | 12% | 14%*** | 14%*** | 10% | 12%*** | 15%*** | 12% | 15%*** | 13%*** |
| Heart Failure | 10% | 14%*** | 15%*** | 8% | 9%*** | 14%*** | 11% | 13%*** | 13%*** |
*
p-value <.05,
**
p-value<.01,
***
p-value<0.001